Semaglutide News and Research

Latest Semaglutide News and Research

Gut immune cells could be responsible for metabolism changes finds study

A new study has shown that the immune cells within the gut could be related to the rate of metabolism. The results of the new study titled, “Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease,” are published in the latest issue of the journal Nature.

31 Jan 2019

New bacterial species may help fight obesity and metabolic disorders

The MyNewGut project has discovered new bacterial species and strains in healthy people that seem to be effective against obesity, metabolic and mental disorders related to stress and obesity (e.g. depression).

17 Dec 2018

New diabetes drugs linked to increased risk of lower-limb amputation and ketoacidosis

The use of a new class of drugs in the treatment of type 2 diabetes, so called SGLT2 inhibitors, are linked to a twofold increased risk for lower-limb amputation as well as diabetic ketoacidosis, a serious diabetes complication.

14 Nov 2018

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces the successful completion of preclinical toxicology testing on the gold nanoparticle carrier system that forms the fundamental basis for Emergex's entire infectious disease vaccine platform.

24 Oct 2018

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.

17 Oct 2018

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.

3 Oct 2018

Genetic score helps predict future major coronary events, shows study

Coronary artery disease (CAD) is the leading killer of people with type 2 diabetes, and it's not a secret killer.

28 Sep 2018

INTEGRA’s electronic pipettes simplify work in GLP environments

Which brand of pipette to use may not be your first consideration when designing your laboratory workflows and SOPs to follow good laboratory practice, but choosing the right pipette can make it much easier to achieve consistent results.

From INTEGRA Biosciences 28 Aug 2018

Insulin resistance largely undetected in non-diabetic patients with Parkinson's disease

Almost two-thirds of non-diabetic patients with Parkinson's disease may be insulin resistant, despite having normal blood sugar, report scientists in the Journal of Parkinson's Disease.

3 Aug 2018

Exenatide treatment improves depression symptoms in PD patients

Non-motor symptoms of Parkinson's disease, such as depression, apathy, cognitive impairment, sleep disorders, and sensory symptoms, can have a greater impact on health-related quality of life than motor deficits.

1 Aug 2018

Hunger hormones could be key to new treatments for drug, alcohol addiction

Hormones that signal the body's state of hunger and fullness could be the key to new treatments for drug and alcohol addiction.

17 Jul 2018

Researchers develop new guide for using mechanical stimulation to enhance tissue-engineered cartilage

Tissue-engineered articular cartilage for repairing cartilage damaged by trauma or disease can be made to more closely mimic natural AC if mechanical stimulation of particular magnitude and duration is applied during the development process.

22 Jun 2018

Researchers discover new medicine that may fight against monogenic obesity

Around two to six per cent of all people with obesity develop obesity already in early childhood; it's in their genetic cards.

4 Jun 2018

Diabetes Care journal features comprehensive EndoBarrier meta-analysis

GI Dynamics Inc., a medical device company that is developing EndoBarrier for patients with type 2 diabetes and obesity, is pleased to announce the meta-analysis, "Effects of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Type 2 Diabetic Patients with Obesity: A Meta-analysis with Secondary Analysis on Weight Loss and Hormonal Changes," by Pichamol Jirapinyo, MD, of Brigham and Women's Hospital in Boston, Massachusetts, and Diplomat of the American Board of Obesity Medicine, has been published in Diabetes Care, the journal of the American Diabetes Association.

10 May 2018

University of Pennsylvania expert investigates novel treatment for cocaine addiction

Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that's why it's so hard to quit using these substances.

28 Apr 2018

Bariatric surgery successes pave way for new type 2 diabetes treatment

Bariatric surgery has long yielded almost immediate health benefits for patients with type 2 diabetes, and new findings on the reasons for remission may be the key to developing drug alternatives to surgery.

25 Apr 2018

Hacking 'drug trafficking' system could increase effectiveness of diabetes treatment

Making tiny changes to existing diabetes treatments can alter how they interact with cells, and potentially make the medicines more effective.

23 Apr 2018

Study compares survival outcomes of different drugs for type 2 diabetes

In a comparison of different classes of drugs used to lower blood sugar levels for patients with type 2 diabetes, sodium-glucose cotransporter 2 (SGLT-2) inhibitors or glucagon-like peptide 1(GLP-1) agonists were associated with a lower risk of death than dipeptidyl peptidase 4 (DPP-4) inhibitors or control (placebo or no treatment).

17 Apr 2018

One class of diabetes drug not associated with reduced risk of death

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings.

17 Apr 2018

New diabetes drug may help obese people shed body weight

A compound that mimics a naturally occurring hormone that regulates appetite may help people who have obesity but not diabetes to lose weight, a new study suggests.

19 Mar 2018

Semaglutide News and Research

Latest Semaglutide News and Research

Gut immune cells could be responsible for metabolism changes finds study

New bacterial species may help fight obesity and metabolic disorders

New diabetes drugs linked to increased risk of lower-limb amputation and ketoacidosis

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

Genetic score helps predict future major coronary events, shows study

INTEGRA’s electronic pipettes simplify work in GLP environments

Insulin resistance largely undetected in non-diabetic patients with Parkinson's disease

Exenatide treatment improves depression symptoms in PD patients

Hunger hormones could be key to new treatments for drug, alcohol addiction

Researchers develop new guide for using mechanical stimulation to enhance tissue-engineered cartilage

Researchers discover new medicine that may fight against monogenic obesity

Diabetes Care journal features comprehensive EndoBarrier meta-analysis

University of Pennsylvania expert investigates novel treatment for cocaine addiction

Bariatric surgery successes pave way for new type 2 diabetes treatment

Hacking 'drug trafficking' system could increase effectiveness of diabetes treatment

Study compares survival outcomes of different drugs for type 2 diabetes

One class of diabetes drug not associated with reduced risk of death

New diabetes drug may help obese people shed body weight

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Semaglutide News and Research

Latest Semaglutide News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in